FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022664678> ?p ?o ?g. }

• W3022664678 abstract "Abstract Healthcare decisions are more effective when the patient voice is included in clinical research, and the Food and Drug Administration encourages the patient’s voice in drug development and regulatory decision-making. Clinical trials should not only demonstrate the effect of a drug on clinical outcomes but should also demonstrate that these outcomes are important or meaningful to patients. Several qualitative and quantitative methods are available to collect patient experience data (e.g., traditional patient-reported outcome [PRO] measures, interviews with clinical trial participants). We aimed to understand if in-depth exit interviews were more effective assessments of the patient experience in recent type 1 diabetes (T1D) clinical trials than existing diabetes-specific PROs. In-depth qualitative interviews were conducted with 41 adults with T1D who had completed or withdrew from a phase 3 study of sotagliflozin, a dual inhibitor of SGLT1 and SGLT2. A targeted literature review was conducted to identify diabetes-specific PROs used in randomized controlled clinical trials of novel T1D medications reported over the past 5 years. Included trials had to investigate a pharmaceutical intervention for adults with T1D and report a diabetes-specific PRO. The concepts assessed in the PRO measures were mapped against those elicited during the 41 exit interviews. A total of 336 publications were identified in the literature search of which 26 were eligible for analysis. Eight diabetes-specific PROs were identified and reviewed from which 54 concepts related to the patient experience were identified. The patient exit interviews included 42/54 (78%) of the patient experience-related concepts identified across all 8 PROs from the literature review. Of the 8 PRO instruments, the Diabetes Quality of Life Measure (DQOL) covered the most concepts (18/54, 33%), followed closely by the Audit of the Diabetes-Dependent Quality of Life (ADDQoL; 16/54, 30%). Some of the most prominent concepts from both approaches were related to impact on life and family; fear of complications; and impact on physical activity, lifestyle and social perceptions. There were several concepts identified in the exit interviews that were not covered in any of the 8 PRO instruments (related to keeping blood sugars within a desired range, ability to manage changes in insulin use). Overall, the exit interviews appeared to provide a more comprehensive picture of patient experience domains. Although existing diabetes PRO measures cover a range of concepts and may adequately assess changes in certain outcomes, data from patient exit interviews provide more comprehensive insights into the patient experience. Exit interview data may provide a more detailed understanding of the disease burden and impact of treatment on improvements in well-being, daily functioning, and treatment satisfaction." @default.
• W3022664678 created "2020-05-13" @default.
• W3022664678 creator A5000860251 @default.
• W3022664678 creator A5016946424 @default.
• W3022664678 creator A5056924334 @default.
• W3022664678 creator A5069292772 @default.
• W3022664678 creator A5075068326 @default.
• W3022664678 creator A5078417799 @default.
• W3022664678 creator A5079937441 @default.
• W3022664678 date "2020-04-01" @default.
• W3022664678 modified "2023-09-26" @default.
• W3022664678 title "MON-630 Elevating the Patient Voice in Type 1 Diabetes Clinical Trials: A Comparison of In-Depth Exit Interviews and Diabetes-Specific Questionnaires" @default.
• W3022664678 doi "https://doi.org/10.1210/jendso/bvaa046.1290" @default.
• W3022664678 hasPublicationYear "2020" @default.
• W3022664678 type Work @default.
• W3022664678 sameAs 3022664678 @default.
• W3022664678 citedByCount "0" @default.
• W3022664678 crossrefType "journal-article" @default.
• W3022664678 hasAuthorship W3022664678A5000860251 @default.
• W3022664678 hasAuthorship W3022664678A5016946424 @default.
• W3022664678 hasAuthorship W3022664678A5056924334 @default.
• W3022664678 hasAuthorship W3022664678A5069292772 @default.
• W3022664678 hasAuthorship W3022664678A5075068326 @default.
• W3022664678 hasAuthorship W3022664678A5078417799 @default.
• W3022664678 hasAuthorship W3022664678A5079937441 @default.
• W3022664678 hasBestOaLocation W30226646781 @default.
• W3022664678 hasConcept C126322002 @default.
• W3022664678 hasConcept C134018914 @default.
• W3022664678 hasConcept C141071460 @default.
• W3022664678 hasConcept C144024400 @default.
• W3022664678 hasConcept C159110408 @default.
• W3022664678 hasConcept C168563851 @default.
• W3022664678 hasConcept C1862650 @default.
• W3022664678 hasConcept C190248442 @default.
• W3022664678 hasConcept C2777180221 @default.
• W3022664678 hasConcept C2780665704 @default.
• W3022664678 hasConcept C2781232474 @default.
• W3022664678 hasConcept C36289849 @default.
• W3022664678 hasConcept C512399662 @default.
• W3022664678 hasConcept C535046627 @default.
• W3022664678 hasConcept C555293320 @default.
• W3022664678 hasConcept C71924100 @default.
• W3022664678 hasConceptScore W3022664678C126322002 @default.
• W3022664678 hasConceptScore W3022664678C134018914 @default.
• W3022664678 hasConceptScore W3022664678C141071460 @default.
• W3022664678 hasConceptScore W3022664678C144024400 @default.
• W3022664678 hasConceptScore W3022664678C159110408 @default.
• W3022664678 hasConceptScore W3022664678C168563851 @default.
• W3022664678 hasConceptScore W3022664678C1862650 @default.
• W3022664678 hasConceptScore W3022664678C190248442 @default.
• W3022664678 hasConceptScore W3022664678C2777180221 @default.
• W3022664678 hasConceptScore W3022664678C2780665704 @default.
• W3022664678 hasConceptScore W3022664678C2781232474 @default.
• W3022664678 hasConceptScore W3022664678C36289849 @default.
• W3022664678 hasConceptScore W3022664678C512399662 @default.
• W3022664678 hasConceptScore W3022664678C535046627 @default.
• W3022664678 hasConceptScore W3022664678C555293320 @default.
• W3022664678 hasConceptScore W3022664678C71924100 @default.
• W3022664678 hasLocation W30226646781 @default.
• W3022664678 hasLocation W30226646782 @default.
• W3022664678 hasOpenAccess W3022664678 @default.
• W3022664678 hasPrimaryLocation W30226646781 @default.
• W3022664678 hasRelatedWork W12039364 @default.
• W3022664678 hasRelatedWork W2037178 @default.
• W3022664678 hasRelatedWork W2442125 @default.
• W3022664678 hasRelatedWork W2450954 @default.
• W3022664678 hasRelatedWork W2611145 @default.
• W3022664678 hasRelatedWork W3784691 @default.
• W3022664678 hasRelatedWork W522470 @default.
• W3022664678 hasRelatedWork W8357788 @default.
• W3022664678 hasRelatedWork W8967363 @default.
• W3022664678 hasRelatedWork W9596678 @default.
• W3022664678 isParatext "false" @default.
• W3022664678 isRetracted "false" @default.
• W3022664678 magId "3022664678" @default.
• W3022664678 workType "article" @default.